Acadia Pharmaceuticals has launched a Phase 3 clinical trial testing the safety and efficacy of ACP-101, an experimental carbetocin…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
Providing needed care for someone with Prader-Willi syndrome (PWS) may make people — particularly those who serve as primary…
Too much insulin — a hormone that controls sugar in blood — may set off weight gain and excessive eating…
A boy was found to manifest “blended” symptoms of both Prader-Willi syndrome (PWS) and a form of hereditary spastic…
A one-time delivery of the brain-derived neurotrophic factor (BDNF) gene into a brain region called the hypothalamus improved metabolism in…
Half of people with Prader-Willi syndrome (PWS) treated with the antipsychotic aripiprazole in a small German study experienced fewer…
Cells of adipose tissue, or body fat, may go awry long before weight gain takes off in children with…
There may be changes to how the “feel-good” hormone oxytocin works in patients with Prader-Willi syndrome (PWS) in general, and…
People with Prader-Willi syndrome (PWS) who had COVID-19 experienced either no symptoms or only mild illness due to the…
Two boys with Prader-Willi syndrome (PWS) developed respiratory failure — a condition in which the oxygen level in the…